Previous studies have shown that canine leukocyte/lymphocyte proliferation is suppressed by the addition of CTLA-4 Ig (30, 31), highlighting its potential application as an immunosuppressant for transplantation and autoimmune disease treatment. Here, CTLA4 is linked to autoimmune disease.